Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03613493 · ClinicalTrials.gov registry record · NA
Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention
A NA study, sponsored by University of Miami.
- Terminated
- Registry status
- NA
- Development phase
- 175
- Enrollment target
NCT03613493: Clinical Trial NA study, sponsored by University of Miami.
NCT03613493 is a NA study that was terminated before completion, run by University of Miami. The registered enrollment target is 175 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03613493, a NA study, was terminated before completion, sponsored by University of Miami.
- TERMINATED
- Registry status
- NA
- Development phase
- 175 participants
- Enrollment target
Study Summary
The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.
Primary Outcome
Number of participants that used and returned their self-sampler kit was evaluated.
Interventions
- BEHAVIORAL Interview
- DIAGNOSTIC_TEST HPV self-sampling kit
- BEHAVIORAL Culturally-targeted Fear Appeal Message
- BEHAVIORAL Fear Appeal Message
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2018-07-10 |
| Est. Completion | 2018-10-01 |
| Phase | NA |
Why NCT03613493 stopped before completion
NCT03613493 is an interventional study that assigns participants to a tested intervention. The registered 175 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Interview is the first listed.
NCT03613493 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03613493 about?
NCT03613493 is a clinical study titled "Acceptability of Human Papillomavirus (HPV) Self-sampling Tools for Cervical Cancer Prevention". The proposed study aims to increase HPV screening behaviors in Jamaican women by examining the acceptability of HPV Deoxyribonucleic Acid (DNA) self-sampling tools, and to determine the most culturally appropriate and effective message design for promoting such a tool in this context.
What is the current status of trial NCT03613493?
This trial is currently terminated. It is a NA study. The enrollment target is 175 participants. The study started on 2018-07-10. Estimated completion is 2018-10-01.
What interventions are being tested in trial NCT03613493?
The interventions under investigation include: Interview (BEHAVIORAL), HPV self-sampling kit (DIAGNOSTIC_TEST), Culturally-targeted Fear Appeal Message (BEHAVIORAL), Fear Appeal Message (BEHAVIORAL).
Who is sponsoring clinical trial NCT03613493?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03613493's enrollment target sits among peer trials
175 610th of 2000 higher than 1,391 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04722341 · 175 participants · NA
Time-Restricted Eating and Cancer: Clinical Outcomes, Mechanisms, and Moderators
- NCT05094037 · 175 participants · NA
Orthotic Treatment of Diabetic Foot Ulcers
- NCT05165745 · 175 participants · NA
Stick2PrEP Cisgender Women and Trans Individuals
- NCT05312255 · 175 participants · NA
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI